SEC Filing Analysis: SANGAMO THERAPEUTICS, INC (SGMO)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An officer disposed of a small number of shares in a non-discretionary transaction to cover tax liabilities from vested Restricted Stock Units (RSUs).
• Market Impact: Negligible. This type of transaction is routine and does not signal a change in the insider's outlook on the company.

Company Information

Field	Value
Company	SANGAMO THERAPEUTICS, INC
Ticker Symbol	SGMO
CIK	0001001233
Industry	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

Field	Value
Name	Davis Gregory D
CIK	0002041855
Title/Position	Head of Research & Technology
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-22
Transaction Code	F - Payment of tax liability by withholding securities
Security Type	Common Stock
Shares Involved	6,708
Price Per Share	$0.66
Total Value	$4,427.28
Shares Owned After	194,514
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$4,427.28
% of Market Cap	0.0023%
Shares Transacted	6,708
% of Shares Outstanding	0.0022%
Post-Transaction Ownership	194,514 shares (0.064% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a $190 million market cap, a transaction of approximately $4,400 is immaterial.
• Ownership Concentration: The insider's post-transaction ownership of 0.064% is not a significant concentration of shares.
• Dilution Impact: Not applicable, as this was a disposition of shares, not an issuance.
• Transaction Significance: The transaction is objectively insignificant, representing less than 0.01% of both market capitalization and shares outstanding. The nature of the transaction (tax withholding) further reduces its importance as a market signal.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The market typically ignores small, non-discretionary sales for tax purposes. The size of the transaction is far too small to have any price impact.

Volume & Sentiment

• Expected Volume Impact: None. The shares were withheld by the issuer and not sold on the open market.
• Sentiment Indicator: Neutral. This filing provides no new information to influence investor sentiment.

Investment Insights

Positive Market Indicators

• None can be derived from this filing.

Risk Factors

• None can be derived from this filing.

Key Takeaways

1. The transaction was a mandatory tax withholding, not a discretionary sale by the insider.
2. The value of the transaction ($4,427) is negligible compared to the company's $190 million market cap.
3. This filing has no signaling value regarding the insider's confidence in the company's future prospects.

Additional Context

Transaction Notes

• Special Circumstances: As noted in the filing's footnote, these shares were automatically surrendered to satisfy tax withholding obligations related to the vesting of RSUs. This is not an open-market trade and does not reflect a decision by the insider to sell.
• Market Environment: This is a routine corporate action related to executive compensation.